Impact of same-day antibiotic susceptibility testing on time to appropriate antibiotic treatment of patients with bacteraemia: a randomised controlled trial

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 4, 2015, Pages 831-838

  Beuving, J ^a,b   Wolffs, P F G ^a   Hansen, W L J ^a   Stobberingh, E E ^a   Bruggeman, C A ^a   Kessels, A ^a   Verbon, A ^a,c  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BLOOD CULTURE; BLOODSTREAM INFECTION; CONTROLLED STUDY; ENTEROCOCCUS; FEMALE; GRAM NEGATIVE BACTERIUM; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS; STREPTOCOCCUS; AGED; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; PROCEDURES; TIME; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 84925533981     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-014-2299-0     Document Type: Article

References (21)

1. Fraser A, Paul M, Almanasreh N et al (2006) Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. Am J Med 119:970–976
2. Ibrahim EH, Sherman G, Ward S et al (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146–155
3. Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596
4. McGregor JC, Rich SE, Harris AD et al (2007) A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis 45:329–337
5. Bouza E, Sousa D, Muñoz P et al (2004) Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results. Clin Infect Dis 39:1161–1169
6. Byl B, Clevenbergh P, Jacobs F et al (1999) Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 29:60–66
7. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A et al (2003) Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 31:2742–2751
8. Kerremans JJ, Verboom P, Stijnen T et al (2008) Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. J Antimicrob Chemother 61:428–435
9. Livermore DM (2005) Minimising antibiotic resistance. Lancet Infect Dis 5:450–459
10. Bruins M, Oord H, Bloembergen P et al (2005) Lack of effect of shorter turnaround time of microbiological procedures on clinical outcomes: a randomised controlled trial among hospitalised patients in the Netherlands. Eur J Clin Microbiol Infect Dis 24:305–313
11. Trenholme GM, Kaplan RL, Karakusis PH et al (1989) Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates. J Clin Microbiol 27:1342–1345
12. Doern GV, Vautour R, Gaudet M et al (1994) Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 32:1757–1762
13. Barenfanger J, Drake C, Kacich G (1999) Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 37:1415–1418
14. Beuving J, Verbon A, Gronthoud FA et al (2011) Antibiotic susceptibility testing of grown blood cultures by combining culture and real-time polymerase chain reaction is rapid and effective. PLoS One 6:e27689
15. Centers for Disease Control and Prevention (CDC) (2014) CDC/NHSN surveillance definitions for specific types of infections. Available online at: http://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf. Accessed 21 July 2014
16. Hansen WL, Beuving J, Bruggeman CA et al (2010) Molecular probes for diagnosis of clinically relevant bacterial infections in blood cultures. J Clin Microbiol 48:4432–4438
17. Donker GA, Deurenberg RH, Driessen C et al (2009) The population structure of Staphylococcus aureus among general practice patients from The Netherlands. Clin Microbiol Infect 15:137–143
18. Paterson DL, Ko WC, Von Gottberg A et al (2004) Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis 39:31–37
19. de Kraker ME, Davey PG, Grundmann H (2011) Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med 8:e1001104
20. Munson EL, Diekema DJ, Beekmann SE et al (2003) Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol 41:495–497
21. Oosterheert JJ, van Loon AM, Schuurman R et al (2005) Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clin Infect Dis 41:1438–1444